Highlights
NASDAQ: INFI       Infinity Pharmaceuti
Last Price Today's Change   Day's Range   Trading Volume
3.95   -0.35 (8.14%)  3.68 - 4.35  2,356,600

Overview

 
Avg Volume (4 weeks):1,805,984
4 Weeks Range:1.91 - 4.38
4 Weeks Price Volatility (%):
82.59%
52 Weeks Range:0.60 - 4.38
52 Weeks Price Volatility (%):
88.62%
Average Price Target: 20.00
Price Target Upside/Downside: +16.05

Headlines



No recent Headlines for this stock.


Business Background

Infinity is a clinical-stage biopharmaceutical company focused on developing novel medicines for the treatment of specific cancers. The company's developed products, and those under development, include therapies targeting hematologic malignancies, or blood cancers; refractory indolent non-Hodgkin lymphoma; refractory chronic lymphocytic leukemia; and solid tumors, including melanoma and non-small cell lung cancer. Infinity has a strategic partnership with AbbVie to develop some of its oncology-related treatments.

  Be the first to like this.
 


APPS
I3 Messenger
Individual or Group chat with anyone on I3investor
 
 

4141  5001  442  76 

ActiveGainersLosers
Top 10 Active Counters
 NameLastChange 
 AMC 4.42-0.29 
 BB 18.03-1.52 
 EXPR 4.15+0.26 
 NOK 4.85+0.31 
 SNDL 0.60-0.033 
 PLTR 36.23+1.77 
 CTRM 0.381-0.026 
 GME 76.79-19.94 
 AAPL 142.92-0.15 
 BNGO 12.58+1.27